Diabetes

Researchers call for paradigm shift in type 2 diabetes treatment

Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management ...

Medical research

Experimental drug achieves unprecedented weight loss

An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers ...

Diabetes

Trends in insulin use, glycemic control explored

(HealthDay)—Since 1988, the proportion of patients with diabetes currently on any insulin has remained stable, according to research published online Dec. 30 in Diabetes Care.

Diabetes

Ranolazine added to glimepiride cuts HbA1c in T2DM

(HealthDay)—For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), according to research published ...

Diabetes

Worse prognosis for prediabetes defined by HbA1c

(HealthDay)—Prediabetes defined by hemoglobin A1c (HbA1c) is associated with worse prognosis than definition by fasting plasma glucose (FPG) or two-hour plasma glucose (2hPG), according to a study published online Feb. ...

page 1 from 15